-
Dr. Adam Rivadeneyra: The promise of biologics + threat of 'bad information'
Adam Rivadeneyra, MD, a sports medicine specialist with Irvine, Calif.-based Hoag Orthopedic Institute, spoke to Becker's Spine Review about his predictions for the field of biologics. - 7/16/19 -
NanoFUSE Biologics cracks Asian market with successful procedure in Thailand
NanoFuse Biologics expanded into Asia after the successful use of its technology in a patient suffering from degenerative spine disease and osteoporosis in Thailand. - 7/11/19 -
DiscGenics tests injectable disc cell therapy for degenerative disc disease
Biotechnology company DiscGenics treated the first Utahns in its nationwide clinical study of injectable disc cell therapy for degenerative disc disease. - 7/10/19
-
California Institute for Regenerative Medicine expected to run out of money — 4 insights
The California Institute for Regenerative Medicine could close after awarding all allocated funds, The Scientist reports. - 7/9/19 -
Federal court bans Florida stem cell company from treating patients, including spinal cord injury
A federal court ordered that Sunrise, Fla.-based regenerative medicine companies US Stem Cell Clinic and US Stem Cell stop providing stem cell treatments to patients, according to the U.S. Department of Justice. - 6/26/19 -
NervGen Pharma launches MS program focusing on nerve remyelination — 3 things to know
NervGen Pharma will use its developing drug technology for spinal cord injuries in a new multiple sclerosis program. - 6/26/19 -
The path to be first — How Carmell Therapeutics could have the 1st BLA-certified regenerative offering for bone healing
Biologics therapies have the promise to revolutionize orthopedics and sports medicine, but unauthorized operators pose a serious threat to emerging therapies. - 6/25/19
-
Cerapedics appoints Patrick O'Connor to executive role — 3 insights
Orthobiologics company Cerapedics appointed Patrick O'Connor to serve as vice president of clinical and market development. - 6/24/19 -
WuXi Biologics launches commercial manufacturing through biologics center expansion — 4 insights
Chinese biologics technology company WuXi Biologics is expanding its conjugation solution center to include commercial manufacturing later this year. - 6/21/19 -
AlloSource joins Advanced Regenerative Manufacturing Institute — 3 insights
AlloSource partnered with Manufacturing USA in a new public-private initiative, the Advanced Regenerative Manufacturing Institute. - 6/19/19 -
Private investment firm invests in Royal Biologics — 4 insights
Granite Creek Capital Partners, a private investment firm in Chicago, invested in regenerative medicine company Royal Biologics. - 6/19/19
-
Ortho RTi unveils new CEO — 4 quick insights
Orthopedic and sports medicine technology company Ortho Regenerative Technologies unveiled Claude LeDuc as its new president and CEO, according to Biospace. - 6/18/19 -
Minnesota seeks to expand stem cell research through state initiative — 4 insights
Regenerative Medicine Minnesota is a bipartisan effort to improve research, technology, education and patient access to regenerative medicine-based treatments. - 6/17/19 -
Stem cell controversies — Where we are in 2019
Regenerative medicine has life-changing potential, but illegal actors are spurring a rash of regulatory activities. - 6/14/19 -
4 key updates in biologics for spine
Here are four key updates in about spinal biologics companies and advancements. - 6/13/19 -
California stem cell clinic scrutinized — 5 insights
East Bay Health and Wellness Center, which offers chiropractic and wellness services in Walnut Creek, Calif., caught the ire of local CBS affiliate KPIX 5 for the unconventional way it markets unproven stem cell treatments. - 6/13/19 -
Biomatrix develops minimally invasive biomaterial to treat intervertebral disc degeneration
NC Biomatrix BV is producing a biomaterial that will assist the treatment of intervertebral disc degeneration in a minimally invasive way, reports Innovation Origins. - 6/13/19 -
Dr. Robert LaPrade on the biggest thing to hit sports medicine since the arthroscope
Robert LaPrade, MD, PhD, a complex knee and sports medicine surgeon, joined Golden Valley, Minn.-based Twin Cities Orthopedics June 3. - 6/12/19 -
Biomaterials startup raises $500K for scaffolds to treat spinal cord injuries
Ottawa, Canada-based biomaterials startup Spiderwort closed a $500,000 oversubscribed friends and family funding round, reports BetaKit. - 6/12/19 -
Ossio wins Frost & Sullivan award for bone regeneration technology — 4 insights
Orthopedic fixation company, Ossio, won the 2019 Frost & Sullivan North America New Product Innovation Award for its bone regeneration device, Ossiofiber. - 6/11/19